High versus low bioavailable oral agents in the treatment of gram negative bloodstream infections

Please join us …

When: Tuesday, April 12, 2022, 12–1 p.m.

Where: Join Zoom Meeting https://us06web.zoom.us/j/86044633057, Meeting ID: 860 4463 3057. Meeting password: 112233

Who: Kwadwo Mponponsuo, MD, MSc, FRCPC; Research Associate, Sunnybrook Research Institute

Topic: High versus low bioavailable oral agents in the treatment of gram negative bloodstream infections

Learning objectives

1. Review current evidence surrounding oral therapy in GN bacteremia.
2. Describe common risks and benefits associated with high and low bioavailable oral agents utilized in GN bacteremia.
3. Discuss the findings of our study from ICES, how it might apply to clinical practice and future directions.

Kwadwo Mponponsuo